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Individual sympathetic varicosities possess dierent sensitivities to
alpha 2 and P2 receptor agonists and antagonists in mouse vas
deferens
1,2S.C. O’Connor, 1,2K.L. Brain & *,1,2M.R. Bennett
1Neurobiology Laboratory, Institute for Biomedical Research, University of Sydney, NSW 2006, Australia and 2Department of
Physiology (F13), University of Sydney, NSW 2006, Australia
1 The diversity of a2 and purinergic autoreceptor actions on action potential evoked calcium
transients in single varicosities has been investigated using the calcium indicator Oregon Green 488
BAPTA-1.
2 During long trains of impulses (10 Hz for 30 s), the change in calcium concentration in
varicosities from its resting level (D[Ca2+]v) increased in many varicosities during the first 3 s of
stimulation before reaching a plateau.
3 The a2 adrenoceptor agonist clonidine (1 mM) decreased D[Ca2+]v by over 40% during short
trains (five impulses at 5 Hz) in most varicosities, although some were unaected. The a2
adrenoceptor antagonist idazoxan (2 mM) increased the D[Ca2+]v plateau following long trains in
most varicosities. Hence, most varicosities possess a2 adrenoceptors which are activated when
noradrenaline accumulates extracellularly.
4 During long trains of impulses, the P2y-purinergic receptor agonist 2-methyl-thio-ATP (100 mM)
decreased D[Ca2+]v plateau by about 50% in most varicosities; a,b-methylene ATP (100 mM)
decreased it by about 50% in a minority of varicosities; adenosine (200 mM) had no significant eect.
Suramin (100 mM) increased the D[Ca2+]v during all stimulus protocols in most varicosities,
suggesting that ambient ATP modulates D[Ca2+]v responses. The P2y receptor antagonist reactive
blue (100 mM) aected a minority of varicosities. Given that most varicosities respond to suramin,
other P2 receptor subtypes are probably present.
5 The ATP ectoenzyme antagonist ARL67157 (50 mM) decreased the plateau D[Ca2+]v during long
trains in complete strings of varicosities but not in others.
6 The present technique indicates that varicosities have diverse autoreceptor utilization.
Keywords: Calcium; sympathetic; varicosities; vas deferens; autoinhibition
Abbreviations: ATP, adenosine triphosphate; BAPTA, bis (O-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid; D[Ca2+]v,
change in calcium concentration in a varicosity from its resting level; class A response, a sustained D[Ca2+]v
plateau during prolonged stimulation; class B response, a slowly recovering D[Ca2+]v during prolonged
stimulation; class C response, a rapidly recovering D[Ca2+]v during prolonged stimulation; class D response, an
increasing D[Ca2+]v during prolonged stimulation; Exp., experiment; Str., string of varicosities; Oregon-BAPTA,
Oregon GreenTM 488 BAPTA-1, 10 kD dextran
Introduction
The ecacy of transmitter release from sympathetic terminal
varicosities during trains of impulses is modulated by
endogenous autoinhibitory substances which include the
cotransmitter noradrenaline (Starke et al., 1989; 1996). The
extent to which these act by modulating the intra-terminal
calcium concentration during and after a train of impulses,
by changing the entry of calcium into the varicosities or
modifying calcium-induced calcium release in the varicosities
or the calcium sequestering processes, is now being
elucidated. It has been recently shown that D[Ca2+]v in
sympathetic varicosities following an impulse or short train
of impulses is due to the influx of calcium ions into the
varicosities and not to a significant contribution of calcium
from intra-varicosity stores (Brain & Bennett, 1997).
Furthermore, the a2 antagonist yohimbine has a profound
eect on D[Ca2+]v amplitude following short trains of
impulses in some sympathetic varicosities without aecting
the sequestering processes (Brain & Bennett, 1997; Cheung et
al., 1998). It is therefore likely, at least during short trains of
impulses, that a2 autoreceptors operate by reducing the
calcium influx, which reduces transmitter release and
subsequently reduces the D[Ca2+]v.
Other autoreceptors exist on sympathetic varicosities.
There are P1-(A1-) purinoceptors (Driessen et al., 1994;
Hoyle et al., 1995), agonists of which decrease the release of
the cotransmitter ATP as indicated by electrophysiological
experiments (Sneddon et al., 1984). The recent discovery that
soluble nucleotidases are released from sympathetic nerve
terminals with the cotransmitters raises the possibility that
adenosine derived from the breakdown of ATP acts on P1-
autoreceptors to inhibit transmitter release (Todorov et al.,
1997). However the P1-purinoceptor antagonist 8-phenyltheo-
phylline does not aect the junctional potentials due to
sympathetic nerve stimulation so that it is uncertain whether
these receptors are functionally relevant (Blakeley et al.,
1988). P2y-purinoceptors also exist on sympathetic varicosities
in the mouse vas deferens (von Kugelgen et al., 1989a). There
is good evidence that these are activated by the endogenously*Author for correspondence; E-mail: maxb@physiol.usyd.edu.au
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released ATP, producing a negative feedback control on ATP
release (von Kugelgen et al., 1994). In the present work an
investigation has been made into whether activation of a2, P2y
and P1 autoreceptors leads to changes in D[Ca2+]v for all or
some varicosities, either during short trains of impulses or
during long trains like those typically used in pharmacolo-
gical experiments in which contraction of the final eector is
observed. In addition, the likelihood that autoreceptors
modify D[Ca2+]v transients by changing calcium influx or
calcium sequestration has been ascertained.
Methods
Tissue preparation
Vasa deferentia were excised frommice (strain Balb/c) aged 5 – 7
weeks. Animals were anaesthetized with CO2 then killed by
cervical fracture. Animal ethics approval was granted by the
Animal Care Ethics Committee, University of Sydney. Both
vasa deferentia were removed, together with the connective
tissue. The epididymal end of each was pinned to a sheet of
Sylgard, and the sheath of epimysium carefully trimmed. This
dissection, and the subsequent loading of the dye, was carried
out in a bath which was continuously perfused with a Ringer’s
solution of the following composition (mM): Na+, 134.7; K+,
4.0; Ca2+, 1.0 – 2.0;Mg2+, 1.0; Cl7, 124.7 – 126.7; HCO3
7, 16.3;
H2PO4
7, 1.7; glucose, 7.8. In order to maintain the pH the
bathing solution was continually bubbled with 95%O2 and 5%
CO2.
The cut prostatic end of the vas deferens was secured in
a suction electrode and immersed in a solution of Oregon
GreenTM 488 BAPTA-1, 10 kD dextran (Oregon-BAPTA;
Molecular Probes). This concentrated indicator solution was
prepared by adding 3 ml of orthophosphate-free ringer’s
solution to 1 mg of the indicator. In each experiment, 0.2 –
0.5 ml of this stock solution was used. The dextran linked
form of the dye allows orthograde transport of the
indicator along the axons to the nerve terminals. The
tissue was then left in the bath for 4 – 5 h to allow time for
the sympathetic axons to load with the dye. While loading,
the bath was covered to prevent photobleaching of the
indicator. The cut end of the vas deferens was then
removed from the Oregon-BAPTA solution but was kept in
the bath solution for a further 0.5 – 3 h to reduce non-
specific staining of the tissue.
Measurement of the calcium transient
The vas deferens was placed in a bath on the stage of an
inverted Leica 4D laser scanning confocal microscope. The
bath was continuously perfused with ringer solution, which
was bubbled in a reservoir to maintain the correct pH. The
base of the bath was a no. 0 coverslip to allow imaging deep
within the tissue while using a relatively short working distance
objective. The prostatic end (which had been exposed to the
dye) was secured in a suction electrode.
The Oregon-BAPTA indicator was excited using an Ar-Kr
laser at a wavelength of 488 nm. Fluorescence images were
captured using the confocal microscope with an oil
immersion 166/0.5 objective, and a 515 nm long pass
emission filter. The vas deferens was stimulated to initiate
action potentials within the axons using an isolated
stimulator (Digitimer DS2) triggered by a Master-8 program-
mable pulse generator (AMPI). The stimulus duration was
kept constant at 0.08 ms throughout all experiments. The
stimulation threshold voltage was determined by finding the
smallest applied voltage amplitude which consistently
produced a response to a single impulse. The vas deferens
was then stimulated at approximately 30% above this
threshold value. This stimulus protocol elicits calcium
transients which are abolished by TTX and are hence
secondary to action potentials (Trout et al., 1999). All
experiments were carried out in the presence of 10 mM
nifedipine and 3 mM prazosin in order to reduce the
movement artefact induced by contraction. It has been
previously shown by us (Brain & Bennett, 1997) that
nifedipine (even at 20 mM) has no significant response on the
amplitude of response to single action potentials (increased
by 1+19%, n=5; P=0.95).
The scan rate of the confocal microscope during experi-
ments (1500 lines s71) was such that a full image (2566256
pixels) was captured every 216 ms (which includes the time for
the scanner to reset between images). The time of exposure of
the sample to the laser was minimized, however a certain
amount of photobleaching and toxicity was unavoidable.
These eects were particularly troublesome for the experiments
involving short trains of impulses since these typically involved
small amplitude calcium transients. In these experiments the
eects of bleaching and toxicity were compensated for by
subtracting the average of several control recordings from the
recording of the evoked response.
Recordings were transferred to a Power Macintosh 6200/75
and processed using NIH Image 1.60. For each varicosity a
region of interest was defined and the mean pixel intensity
within this region determined for every image in the recording.
Any variation in the position of the varicosity was accounted
for by an automated procedure which tracked the varicosity
between frames by locating the strongest local fluorescence
signal compared with the background (Brain & Bennett, 1997).
In this way a record of the variation of the mean fluorescent
intensity following an action potential, within a single given
varicosity, was obtained.
The change in fluorescence was converted to a change in
calcium concentration via a relationship derived previously for
this preparation (Brain & Bennett, 1997). Significance was
evaluated with a Student’s two-tailed, paired t-test. Unless
otherwise stated, all errors quoted are standard errors of the
mean. The recovery of D[Ca2+]v following stimulation was
modelled by fitting the data to a double exponential function
(Brain & Bennett, 1997).
To test for heterogeneity in the response of dierent
varicosities to each drug the following method was used. The
null hypothesis was that all varicosities are equally aected
by each experimental protocol. In each experimental protocol
the average eect of the drug was calculated. An expected
response from each varicosity in the presence of the drug was
calculated, based on its control response and assuming the
null hypothesis. The measured response was compared with
the expected response. When at least 25% of the varicosities
(and at least two varicosities) had a measured response that
was statistically significantly dierent (P50.05) from the
expected response then the null hypothesis is violated and
hence the response to the experimental protocol was called
heterogenous.
2-methylthioadenosine 5’-triphosphate, a,b-methyleneade-
nosine 5’-triphosphate, adenosine, basilen (reactive) blue E-
3G, idazoxan, nifedipine, prazosin hydrochloride and suramin
were obtained from Sigma Aldrich Pty. Ltd. (Sydney,
Australia). Clonidine was obtained from Research Biochem-
icals International, distributed by Australian Laboratory
Services (Sydney, Australia).
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Results
The eect of long trains of impulses on D[Ca2+]v in
dierent varicosities
Stimulation of the sympathetic nerve terminals with trains of
impulses at 10 Hz for 30 s led, in many varicosities, to an
increase in D[Ca2+]v over the first 3 s of stimulation until a
plateau level of D[Ca2+]v was reached that was sustained for
almost the entire period of stimulation (Figures 1a and 2a).
However, in some varicosities the D[Ca2+]v initially
increased, but then declined before the end of the train
(Figure 2b,c). In other varicosities, the D[Ca2+]v increased
throughout the period of stimulation (Figure 2d). The
average D[Ca2+]v response within each of these four
categories are shown in Figure 2e. Varicosities that gave a
sustained D[Ca2+]v plateau during stimulation predominated
(see class A in Figure 2f).
The eect of dierent frequencies of stimulation of
varicosities that showed a sustained plateau D[Ca2+]v (that is,
showed a class A response) was determined. Increasing the
frequency of stimulation between 1 and 10 Hz gave plateau
values of D[Ca2+]v that increased with the frequency (Figure
3a – c). A plot of the average value of D[Ca2+]v over all seven
varicosities that were tested in this way showed that whilst the
plateau D[Ca2+]v increased with frequency, this relationship
was non-linear, with the higher frequencies showing a smaller
value of plateau D[Ca2+]v than that expected from the plateau
D[Ca2+]v at the lower frequencies (Figure 3d). Treating this as
a linear relationship gave a 25 nM increase in the plateau
D[Ca2+]v for each 1 Hz increase in frequency.
The eect of an a2 receptor agonist on D[Ca2+]v
The a2 receptor agonist clonidine (1 mM) significantly
decreased the peak D[Ca2+]v due to a single impulse in only
a small minority of varicosities (Figure 4a). The decrease in
D[Ca2+]v amounted to about 52% in two out of nine
varicosities (nv=9) on five strings (ns=5) studied in three
preparations (ne=3; Figure 4e). The two aected varicosities
were on the same string which also possessed a varicosity that
was not aected (open triangle in Figure 4e). Clonidine
aected the peak D[Ca2+]v due to short trains of impulse (five
impulses at 5 Hz) in over 50% of the varicosities studied,
decreasing the D[Ca2+]v peak by about 45% (Figure 4b). One
string showed no eects of clonidine (filled square, Figure 4f),
another possessed only one varicosity that was aected (filled
circle, Figure 4f), whereas five out of six varicosities were
aected on two other strings close to each other in the same
preparation (triangles, Figure 4f; nv=11, ns=4, ne=3). The
rate of calcium recovery following a single impulse or short
trains of impulses was unaected by clonidine in any varicosity
studied (Figure 4c,d).
The plateau D[Ca2+]v during long trains of impulses (10 Hz
for 30 s) was greatly decreased by clonidine in the majority of
varicosities (Figure 5a). Significant decreases were observed in
five varicosities (nv=9, ns=4, ne=4), with in some cases a
decrease of over 75% (Figure 5b). However some strings
possessed varicosities that did not show any changes at all,
whilst other strings possessed a minority of varicosities which
did not show significant changes (Figure 5b). It is interesting to
note that the varicosities with the highest control plateaus seem
to be most aected by clonidine (Figure 5b). Overall, the
response to clonidine was heterogenous (as described in the
Methods) following single impulses, short trains and long
trains of impulses.
The eect of an a2 receptor antagonist on D[Ca2+]v
A check was next made of the ability of endogenously released
noradrenaline to aect the a2 receptors on varicosities, using
the a2 receptor antagonist idazoxan (2 mM). This drug only
aected the peak D[Ca2+]v following a single impulse by
increasing it in a small minority of varicosities (Figure 6a).
Only three varicosities were aected in this way, with the
majority of strings of varicosities showing no significant
changes in D[Ca2+]v (Figure 6d; nv=10, ns=5, ne=3). The
peak D[Ca2+]v during a short train of impulses was also
elevated significantly in only a small minority of varicosities
(Figure 6b,e). Only three varicosities showed a significant
increase in their peak D[Ca2+]v, and each of these was on a
separate string (Figure 6e; nv=12, ns=5, ne=3). The rate of
calcium sequestration, modelled as the sum of two exponen-
tials, following single impulses or short trains of impulses was
unaected by idazoxan in any varicosity (for single impulses:
control component amplitudes of 23+5 and 13+3 nM with
time constants of 3.9+1.2 and 0.19+0.05 s respectively;
idazoxan component amplitudes of 24+4 and 19+4 nM with
time constants of 5.6+1.7 and 0.23+0.12 s respectively. For
short trains of impulses: control component amplitudes of
74+21 and 74+18 nM with time constants of 1.0+0.2 and
0.7+0.2 s respectively; idazoxan component amplitudes of
70+16 and 80+19 nM with time constants of 2.5+0.8 and
0.31+0.06 s respectively).
The plateau D[Ca2+]v reached during long trains of impulses
in the presence of idazoxan was increased in a majority of
varicosities (Figure 6c,f). Significant increases of about 80%
were detected in six varicosities (nv=11, ns=5, ne=4), with all
three varicosities on one string being aected (filled squares,
Figure 6f) and none on another (filled triangles, Figure 6f).
The response to idazoxan was heterogenous (as described in
the Methods) following single impulses and long trains of
impulses. These observations on the eects of clonidine and
Figure 1 Images of Oregon Green 488 BAPTA-1 fluorescence in a
string of varicosities during long trains of impulses before and after
the introduction of clonidine. Images of the fluorescent signal are
shown before, during and after a train of impulses at 10 Hz for 30 s
for a string of varicosities under control conditions (a) and in the
presence of clonidine (b; 1 mM). Stimulation commenced immediately
after the first image and ended just before the last image. Successive
images are separated by 8.64 s and displayed in chronological order
(left to right). Calibration bar is 2 mm. The brighter parts of the
image correspond to greater measured fluorescent intensity.
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idazoxan suggest that about half of the varicosities possess a2
receptors, that many of these varicosities are on the same
string, and that as the endogenous release of noradrenaline is
increased by long trains of impulses most of these varicosities
have their D[Ca2+]v modulated.
The eect of purinergic receptor agonists on D[Ca2+]v
The eect of dierent P2 and P1 receptor agonists on D[Ca2+]v
was next investigated in order to determine if such receptors
exist on varicosities and modulate D[Ca2+]v. The P2y receptor
Figure 2 Dierent varicosities show dierent patterns of D[Ca2+]v during long trains of impulses. (a – d) show the average change
in D[Ca2+]v during stimulation at 10 Hz for 30 s for four dierent varicosities and the changes some 15 min later in response to the
same stimulus protocol. The pattern of change in D[Ca2+]v is reproducible in each varicosity. (e) gives the average D[Ca
2+]v at
intervals of 10 s, with t=0 being the beginning of stimulation, for all varicosities studied in the present work (nv=78) that are
referred to as classes A to D, illustrated in (a – d). (f) gives the frequency distribution of varicosities with a particular class of
D[Ca2+]v response.
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agonist 2-methyl-thio-ATP (100 mM) decreased the plateau
D[Ca2+]v during stimulation with long trains of impulses for
30 s at 10 Hz (Figure 7a). This occurred in nearly all
varicosities examined (Figure 7d; nv=9, ns=7, ne=4)
consistent with the idea that most varicosities possess P2y
autoreceptors, but the amplitude of the change was hetero-
genous. The P261/P263 receptor agonist a,b-methylene ATP
(100 mM) reduced the plateau D[Ca2+]v during long trains of
impulses (Figure 7b), in a minority of varicosities (Figure 7e;
nv=8, ns=5 and ne=4), indicating that most varicosities do
not possess P2x receptors. The response to a,b-methylene ATP
was heterogenous (as described in the Methods). There was no
evidence for an action of the P1 receptor agonist adenosine
(200 mM), as this did not aect the size of D[Ca2+]v following
long trains of impulses (Figure 7f; nv=6, ns=2, ne=2). These
observations suggest that P2y receptors exist on sympathetic
varicosities for the modulation of D[Ca2+]v with only some of
these possessing P2x receptors.
The eect of purinergic receptor antagonists on
D[Ca2+]v
The eects of the P2 receptor antagonist suramin were next
determined in order to check if D[Ca2+]v is modulated through
endogenously released ATP acting on P2 receptors on
varicosities. Suramin (100 mM) increased the peak D[Ca2+]v
significantly following a single impulse in the majority of
varicosities (Figure 8a). In three strings of the four examined,
each possessed at least one varicosity that was aected by
suramin, which increased D[Ca2+]v by up to 100% independent
of the peak D[Ca2+]v in the control solution (Figure 8d; nv=10,
ns=4, ne=3). Suramin increased the peak D[Ca2+]v signifi-
cantly during short trains of impulses in nearly all varicosities
(Figure 8b). All strings possessed varicosities that showed
substantial increases in D[Ca2+]v, sometimes over 100%
(Figure 8e; nv=11, ns=3, ne=3). The plateau D[Ca2+]v was
also increased substantially during long trains of impulses in
many varicosities (Figure 8c). In six varicosities there were
significant increases in D[Ca2+]v of about 80% (nv=14, ns=6,
ne=3), although all the varicosities on three of the strings
examined failed to increase plateau D[Ca2+]v. The response to
suramin was heterogenous (as described in the Methods)
following short trains and long trains of impulses. Suramin did
not aect the rates of calcium sequestration after single
impulses or short trains of impulses (for single impulses:
control component amplitudes of 53+9 and 8+5 nM with
time constants of 2.5+0.3 and 0.9+0.5 s respectively; suramin
component amplitudes of 70+12 and 33+10 nM with time
Figure 3 The plateau D[Ca2+]v in class A responses during a long train increases with stimulation frequency. (a – c) show the
D[Ca2+]v response during dierent frequencies of stimulation in a single varicosity with a class A response. (d) gives the relationship
between the D[Ca2+]v at 20 s into the stimulation train and the frequency of stimulation for seven varicosities.
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Figure 4 Clonidine decreases D[Ca2+]v in some varicosities following an impulse but in a majority of varicosities during short
trains of impulses without changing the rate of sequestration of D[Ca2+]v. (a and b) show the typical D[Ca
2+]v response before,
during and following a single impulse and a short train of five impulses at 5 Hz, respectively, during a class A response in a single
varicosity in response to clonidine (1 mM). (c and d) show the average changes in D[Ca2+]v from eight varicosities on log-linear
coordinates following the stimulation protocols given in (a) and (b) respectively; if a double exponential curve is fitted to these
results then the following amplitudes and time constants are obtained (c) control amplitudes of 31+4 and 13+3 nM with time
constants of 4.0+0.7 and 0.15+0.09 s respectively; clonidine amplitudes of 26+3 and 5+2 nM with time constants of 1.7+0.2 and
0.1+0.1 s respectively. (d) control amplitudes of 76+16 and 22+6 nM with time constants of 3.2+1.1 and 0.22+0.7 s respectively;
clonidine amplitudes of 51+5 and 12+6 nM with time constants of 1.7+0.4 and 0.02+0.08 s respectively). (e) gives the average
peak D[Ca2+]v due to a single impulse in the presence of clonidine plotted against that in the control solution. (f) gives the average
peak D[Ca2+]v amplitude due to a short train of impulses (five impulses at 5 Hz) in the presence of clonidine plotted against that for
the same varicosity in control solution.
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constants of 4.1+0.7 and 0.8+0.2 s respectively. For short
trains of impulses: control component amplitudes of 103+22
and 18+8 nM with time constants of 1.7+0.2 and 0.04+0.14 s
respectively; suramin component amplitudes of 210+57 and
32+57 nM with time constants of 1.8+0.4 and 0.26+0.20 s
respectively).
These observations on the eects of suramin indicate that P2
receptors are under tonic control by endogenous ATP. Given
the observations that 2-methyl-thio-ATP aects the plateau
D[Ca2+]v in most varicosities, described above, the results with
suramin suggest that it is the P2y subclass of P2 receptors on
varicosities which are under the control of endogenously
released ATP. In order to check this, the eects of the P2y
antagonist reactive blue (100 mM) on the D[Ca2+]v of
varicosities was next examined. Reactive blue did not increase
the D[Ca2+]v due to a single impulse in any of the varicosities
studied (Figure 9a,d; nv=9, ns=6, ne=3). Reactive blue also
had little eect on the peak D[Ca2+]v reached during short
trains of impulses (Figure 9b), with only one varicosity
showing a significant increase in D[Ca2+]v (Figure 9e; nv=14,
ns=7, ne=4). The plateau D[Ca2+]v reached during long trains
was increased by reactive blue at a greater number of
varicosities than for short trains (Figure 9c).
Four varicosities showed a significant increase in D[Ca2+]v
(nv=12, ns=4, ne=3), with two of these occurring on the same
string and each of the others on a single string, so that one
string possessed varicosities that showed no eects at all
(Figure 9f). Overall, the response to Reactive blue was
heterogenous (as described in the Methods) following all
stimulus protocols. These results show that most varicosities
are not aected by reactive blue at any of the protocols of
stimulation used whereas they are by suramin, indicating that
types of P2 receptors other than P2y might be involved in the
modulation of D[Ca2+]v.
The eect of ATPase antagonists on D[Ca2+]v
In order to see if ecto-ATPases limit the amount of ATP acting
on the P2y autoreceptors, the eects of the ATP ectoenzyme
antagonist ARL 67157 on D[Ca2+]v were determined. ARL
67157 (50 mM) significantly decreased the plateau D[Ca2+]v
following a long trains of impulses by about 45% in all four
varicosities on two strings in one preparation but did not
decrease the plateau D[Ca2+]v in any of the other varicosities
on three other strings in three other preparations (nv=12,
ns=5, ne=4; Figure 10).
Discussion
While the most common type of response of a varicosity to
prolonged stimulation was the establishment of a relatively
stable plateau of elevated D[Ca2+]v (i.e. a class A response),
this was not the only type of response. In some varicosities the
D[Ca2+]v began to decline from its peak before the end of the
stimulus train (class B and C responses). It may be that in these
varicosities the decline in the peak corresponds with the onset
of presynaptic autoinhibition of the calcium influx (which may
be adrenergic, purinergic or peptidergic). Alternatively, the
kinetics of calcium removal or sequestration may change
during the stimulus train. For example, the activity of the
calcium pump may be upregulated in the presence of an
increase in intracellular calcium concentration via a Ca2+-
calmodulin-dependent pathway (for review, see Monteith &
Roufogalis, 1995), which would lead to either the class B or C
responses. It is also possible that the class B and C responses
occur as a result of an increasing number of failures to initiate
action potentials during the course of prolonged stimulation.
We have observed such failures during long trains of stimuli
with line scanning confocal microscopy through single
varicosities (unpublished observation). The class D responses
(which were relatively rarely observed) may occur in
varicosities in which calcium sequestration mechanisms begin
to fail as the stimulus train progresses.
A linear relationship between the stimulation frequency and
the plateau D[Ca2+]v is theoretically expected if calcium is
removed from the varicosities by a first order process (see the
Appendix). Using the measured value of the stimulus
frequency versus D[Ca2+]v plateau of 25 nM s71, and assuming
that only the first component of D[Ca2+]v sequestration (time
Figure 5 Clonidine decreases the D[Ca2+]v plateau in most varicosities during long trains of impulses. (a) an example of the plateau
D[Ca2+]v reached in a varicosity during stimulation at 10 Hz for 30 s in response to clonidine. (b) gives the average changes in the
plateau amplitude of D[Ca2+]v due to a long train of impulses in the presence of clonidine plotted against the average value of
D[Ca2+]v for the same varicosity in the control solution.
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constant of 0.42+0.05 s; Brain & Bennett, 1997) is significant
in determining the plateau concentration, then the change in
calcium concentration per impulse is predicted from the
derivation in the Appendix to be about 60 nM. This is in
agreement with the D[Ca2+]v peak of 65+12 nM measured
following single impulses that we have previously reported
(Brain & Bennett, 1997). The observed non-linearity of the
relationship between frequency and plateau amplitude may be
due to more complicated kinetics of calcium sequestration than
assumed by the simple first order model.
Figure 6 Idazoxan mainly aects D[Ca2+]v following long trains of impulses. Typical D[Ca
2+]v responses during and following a
single impulse (a), a short train of impulses (b; five impulses at 5 Hz) and a long train of impulses (c; 30 s of stimulation at 10 Hz)
in a varicosity of response class A in response to idazoxan (2 mM). (d – f) give the changes in the D[Ca2+]v peak or plateau in the
presence of idazoxan for a number of a number of varicosities following a single impulse, a short train of impulses and a long train
of impulses respectively. Each symbol gives the average changes in D[Ca2+]v peak or plateau in the presence of idazoxan plotted
against that for the same varicosity in the control solution.
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The eect of a-receptor agonists and antagonists on
D[Ca2+]v
Clonidine on average decreased D[Ca2+]v during short trains of
impulses by about 40% and during long trains by an even
greater percentage in the large majority of varicosities without
changing the kinetics of sequestration of calcium, indicating
that most varicosities possess a2 receptors. It is known that
prazosin has considerably anity for both a2B and a2C
adrenoceptors, with pKi for the human isoforms of 7.0 and
Figure 7 2-methyl-thio-ATP decreases the D[Ca2+]v plateau during long trains of impulses whereas neither a,b-methylene ATP nor
adenosine has much eect. (a – c) show the eects on D[Ca2+]v of stimulating with long trains of impulses (10 Hz for 30 s) in the
presence of 2-methyl-thio-ATP (100 mM), a,b-methylene ATP (100 mM) and adenosine (200 mM) respectively. (d – f) give the changes
in the size of D[Ca2+]v in the presence of 2-methyl-thio-ATP, a,b-methylene ATP and adenosine respectively for a number of
varicosities. Each symbol gives the average changes in the amplitude of D[Ca2+]v in the presence of the drug plotted against the
average value of D[Ca2+]v for the same varicosity in the control solution.
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7.1 respectively (Marjama¨ki et al., 1993). As the present
experiments were carried out in 3 mM prazosin, with the aim of
blocking contraction via inhibition of a1 receptors, we are
unable to comment on the presence or action of either a2B or
a2C adrenoceptor mechanisms in the varicosities. The failure of
clonidine to decrease D[Ca2+]v due to a single impulse, except
in a small minority of varicosities, was surprising. Although it
has been shown previously that clonidine can decrease
D[Ca2+]v due to a single impulse (Brain & Bennett, 1997), the
proportion and disposition of varicosities which behave in this
Figure 8 Suramin increases D[Ca2+]v following an impulse and during short and long trains of impulses in most varicosities. (a – c)
show the typical changes in D[Ca2+]v during and following a single impulse, a short train of impulses (five impulses at 5 Hz) and a
long train of impulses (30 s of stimulation at 10 Hz) in a varicosity of response class A in response to suramin (100 mM). (d – f) give
the changes in the size of D[Ca2+]v in the presence of suramin for a number of varicosities following a single impulse, a short train
of impulses and a long train of impulses respectively. Each symbol gives the average changes in the amplitude of D[Ca2+]v in the
presence of idazoxan plotted against the average value of D[Ca2+]v for the same varicosity in the control solution.
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Figure 9 Reactive blue does not increase D[Ca2+]v during an impulse or following a short train of impulses but does in a minority
of varicosities during long trains of impulses. Typical changes in D[Ca2+]v response during and following a single impulse (a), a
short train of impulses (b; five impulses at 5 Hz) and a long train of impulses (c) 30 s of stimulation at 10 Hz) in a varicosity of
response class A in response to reactive blue (100 mM). (d – f) give the changes in the D[Ca2+]v peak or plateau in the presence of
reactive blue for a number of varicosities following a single impulse, a short train of impulses and a long train of impulses
respectively. Each symbol gives the average changes in the amplitude of D[Ca2+]v in the presence of reactive blue plotted against
that for the same varicosity in the control solution. Reactive blue had no eect on the rates of sequestration of calcium following
either an impulse or short trains of impulses (for single impulses: control amplitudes of 16+2 and 12+5 nM with time constants of
6.8+3.9 and 0.17+0.06 s respectively; reactive blue amplitudes of 17+6 and 12+3 nM with time constants of 5.8+4.0 and
0.17+0.04 s respectively. For short trains of impulses: control amplitudes of 49+7 and 27+5 nM with time constants of 4.1+2.6
and 0.11+0.07 s respectively; reactive blue amplitudes of 45+7 and 33+7 nM with time constants of 1.7+0.3 and 0.20+0.07 s
respectively).
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way was not established. It seems that the agonist eects of
clonidine can only be detected when there is a substantial
influx of calcium into the varicosities as occurs during trains of
impulses. However, even during trains of impulses these eects
of clonidine on D[Ca2+]v were quite heterogeneous across
varicosities, with some strings of these remaining entirely
unaected and other strings possessing some aected
varicosities next to unaected varicosities. The unaected
strings existed in too high a number to be attributed to sensory
endings, and furthermore all their varicosities showed calcium
transients on arrival of a nerve impulse, so that the possibility
exists that these strings might belong to terminals that do not
release noradrenaline. It is likely that clonidine modulates
D[Ca2+]v by decreasing the calcium influx through an N-type
like voltage-dependent calcium channel. a2 receptors on
sympathetic neurons inhibit calcium influx through an N-type
calcium channel (Boehm & Huck, 1996) although in
sympathetic nerve terminals the a2 receptor mediated changes
in transmitter release occur via an o-conotoxin GVIA resistant
channel, which is nevertheless a voltage-sensitive calcium
channel as it is blocked by cadmium ions (Brock & Cunnane,
1995; Smith & Cunnane, 1996; 1998).
Idazoxan on average increased D[Ca2+]v for short trains of
impulses without changing D[Ca2+]v during a single impulse,
consistent with the previously reported action of the a2-
antagonist yohimbine (Brain & Bennett, 1997). These results
are also consistent with electrophysiological analysis of the
eects of these agents on junction potentials in the vas
deferens, with clonidine depressing all the junction potentials
during a train (Illes & Starke, 1983; Blakeley et al., 1984) and
yohimbine increasing all the junction potentials in a train
except for the first one (Illes & Starke, 1983; Brock et al.,
1990). These results are to be expected given the fact that the
cotransmitter noradrenaline released by an impulse does not
act on a2 autoreceptors to modulate transmitter release by the
same impulse (Story et al., 1981; Mayer et al., 1988). The
observation that D[Ca2+]v was unaected by idazoxan during
long trains of impulses in whole strings of varicosities is
consistent with the failure of clonidine to aect whole strings
of varicosities under the same stimulation paradigm, and
reinforces the conclusion that some terminals do not possess a2
adrenoceptors at all.
The eect of purinergic receptor agonists and
antagonists on D[Ca2+]v
The P1 receptor agonist adenosine had no significant eect on
the great majority of varicosities. On the other hand the P2y
agonist 2-methyl-thio-ATP had a profound eect in decreasing
D[Ca2+]v during long trains of impulses in nearly all
varicosities, pointing to a widespread distribution of this
receptor on varicosities. The P2x receptor agonist a,b-
methylene ATP aected a minority of varicosities, indicating
that this receptor is not widely distributed over varicosities.
The significant eect of the P2 receptor antagonist suramin
on varicosities indicates the activation of the P2y receptor by
endogenous ATP. Suramin increased the amplitude of
D[Ca2+]v for single impulses as well as for short and long
trains of impulses in a high proportion of varicosities without
aecting the kinetics of sequestration. Suramin is an
antagonist at P2-purinoceptors (Dunn & Blakeley, 1988),
blocking membrane currents due to the eects of exogenous
ATP acting at P2x receptors on isolated smooth muscle cells
(Hoiting et al., 1990), the purinergic (P2x) phase of the
contraction of the vas deferens (von Kugelgen et al., 1989b;
Mallard et al., 1992) as well as the excitatory junction potential
in the vas deferens due to ATP acting on P2x receptors
(Sneddon, 1992). However suramin tends to potentiate the
contractions produced by exogenous ATP on the vas deferens
(Bailey & Hourani, 1994; Reilly & Hirst, 1996). This apparent
contradiction is probably resolved by the discovery that
suramin has direct inhibitory eects on ectonucleotidases
(Hourani & Chown, 1989; Stout & Kirley, 1995; Ziganshin et
al., 1995; Kennedy & Le, 1995; also see below). Exogenous
ATP is hydrolysed to adenosine by membrane bound
ectonucleotidases; the inhibition of the ectonucleotidases with
suramin will protect the ATP from hydrolysis and so enhance
the contractile response. However the potentiating eect of
Figure 10 Ecto-ATPase antagonist (ARL 67157) decreases D[Ca2+]v during long trains of impulses in a small minority of
varicosities. (a) shows the typical changes in D[Ca2+]v during and following a long train of impulses (30 s of stimulation at 10 Hz) in
a varicosity of response class A in response to ARL 67157 (50 mM). (b) gives the changes in the D[Ca2+]v in the presence of ARL
67157 for a number of varicosities following a long train of impulses. Each symbol gives the average changes in the amplitude of
D[Ca2+]v in the presence of ARL 67157 plotted against the average value of D[Ca
2+]v for the same varicosity in the control
solution.
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suramin on D[Ca2+]v is unlikely to be due to D[Ca2+]v being
protected from a negative feedback eect normally exerted by
adenosine but failing to occur in the presence of this inhibitor
of the ectonucleotidases, as exogenous adenosine had little
eect on D[Ca2+]v in any varicosity studied. It is interesting in
this regard that Blakeley et al. (1988) could find no evidence
for an endogenous eect of adenosine in modulating
transmission in the vas deferens.
The D[Ca2+]v due to a single impulse was increased
significantly by suramin in most varicosities. As it is unlikely
that ATP released by an impulse can act back on the varicosity
from which it is released to modulate secretion by the same
impulse, it seems that there is an ambient level of ATP (or
another endogenous P2-receptor agonist) present at the
varicosities in the absence of impulses that regulates the
D[Ca2+]v. There is evidence to suggest that suramin increases
the overflow of transmitter from the vas deferens for long trains
of impulses, but not for short trains, an observation that has
been interpreted as showing the necessity for prolonged nerve
activity before the negative feedback mediated by the P2y
autoreceptors is operative (von Kugelgen et al., 1993). It might
be that a sustained release of ATP from varicosities occurs in
the absence of nerve impulses, as indicated by the spontaneous
excitatory junction potentials in the vas deferens (Burnstock &
Holman, 1962), or that there is a spontaneous release of ATP
from smooth muscle cells (Kurz et al., 1994; Henery et al. 1999).
This spontaneous ATP release could provide a tonic inhibitory
eect on evoked release of transmitter through a tonic down
regulation of calcium channels on varicosities. During trains of
impulses evoked release probably adds to the spontaneous tonic
release that aects D[Ca2+]v. This would explain the increase in
the extent to which suramin enhanced D[Ca2+]v during a short
train of impulses (on average about 105%) compared with that
for a single impulse (on average about 90%).
Given the extensive eects of 2-methyl-thio-ATP and
suramin on the D[Ca2+]v transient in most varicosities, the
paucity of eects of the P2y antagonist reactive blue 2
(Burnstock & Warland, 1987) was surprising. Reactive blue 2
acts in the mouse vas deferens to greatly increase the overflow
of stimulation-evoked noradrenaline (von Kugelgen et al.,
1994). However reactive blue had little eect in potentiating
D[Ca2+]v compared with that of suramin for either a single
impulse or short trains of impulses, indicating that it is unlikely
that suramin is only blocking P2y receptors on the varicosities,
and perhaps pointing to a more eective role of P2x receptors
on varicosities than revealed in the present study.
The eect of ARL 67157 on D[Ca2+]v
The newly synthesized ATPase ectonucleotidase inhibitor
ARL 67157 (formerly FPL 67156) decreased D[Ca2+]v during
trains of impulses for some varicosities but not for others. This
result is to be expected if the released ATP in the vas deferens is
partly metabolized by ATPases before it acts on P2y
autoreceptors to inhibit evoked transmitter release: protecting
ATP from metabolism then increases the availability of ATP
to act on these autoreceptors and so down-regulate the
voltage-dependent calcium channels that control the evoked
influx of calcium ions and hence D[Ca2+]v. The fact that ARL
67157 also potentiates the contraction of the vas deferens in
response to exogenous ATP (Crack et al., 1995) is simply
explained on the eect of this agent in protecting the
exogenous ATP from metabolism, and hence increasing its
concentration at the postjunctional P2x receptors. The recent
discovery that soluble nucleotidases are secreted along with
ATP during evoked transmitter release and that these
nucleotidases are inhibited by suramin and ARL 67157 adds
a new dimension to the pharmacological analysis of purinergic
transmission (Todorov et al., 1997). ATP metabolism would be
prevented by inhibition of this secreted nucleotidase, thus
giving a greater depression of D[Ca2+]v during trains of
impulses than for single impulses, as is observed.
Heterogeneity of autoreceptors on varicosities
In this investigation, changes in D[Ca2+]v have been used to
determine the actions of adrenergic and purinergic agents on
single varicosities. Of course if a particular agent exerts its
eect on the varicosities by other means than altering calcium
influx or sequestration then this approach is of no use.
Adenosine, which is known in many synapses to modulate
calcium currents (see for example Bennett & Ho, 1992) failed
to have any eect on D[Ca2+]v in any varicosities but one. It
seems most likely that the P1 receptors that mediate the action
of adenosine are rarely present on varicosities.
The possibility that the calcium influx from one varicosity
contributes to the D[Ca2+]v recorded in adjacent varicosities
has been examined previously using line scans through the
varicosities and shown not to occur following a single impulse;
there was, however, some evidence for diusion of calcium
between varicosities during relatively sustained spontaneous
elevations in D[Ca2+]v (lasting over seconds) that sometimes
occur in varicosities (Brain & Bennett, 1997). These observa-
tions suggest that changes in D[Ca2+]v that occur in a
varicosity during long trains might be coupled to the changes
in D[Ca2+]v that occur in adjacent varicosities. Thus, the
present observations of diverse changes in D[Ca2+]v plateau in
dierent varicosities exposed to adrenergic and purinergic
agonists and antagonists point to even greater diversity in the
distribution of receptors on varicosities. For example, the
actions of clonidine on D[Ca2+]v during long trains of impulses
indicate that whilst a majority of varicosities were aected
there exist whole strings of varicosities that were not and which
therefore are unlikely to possess a2 receptors. Furthermore
some varicosities on the same string responded to clonidine,
while adjacent ones did not, suggesting that any coupling
between the varicosities was too weak to remove the eects of
receptor distribution diversity. In contrast, the actions of 2-
methyl-thio-ATP on D[Ca2+]v during long trains indicated that
most varicosities possessed P2y receptors.
The eects of the antagonists to a2 and P2 receptors on
D[Ca2+]v during trains of impulses pointed to the importance
of the pooling in the extracellular space of noradrenaline and
ATP released from many dierent sites in the process of
autoinhibition. Thus the number of varicosities showing
significant eects on D[Ca2+]v to idazoxan was increased
during long trains of impulses compared with short trains. If
there is no significant pooling of calcium between varicosities
during long trains, as discussed above, then the increasing
eects of idazoxan at longer trains may be attributed to the
greater concentration of noradrenaline in the extracellular
space.
It is important to consider the presence of non-sympathetic
axons and terminals within the vas deferens. In the monkey vas
deferens, about 0.1% of varicosities are sensory (Type V
varicosities; Leong & Singh, 1989). Acetycholinesterase
positive fibres are most densely distributed in the lamina
propria, but are also present in the inner part of the smooth
musculature. If these results hold for the mouse, then it would
be very unlikely that any of the varicosities viewed in these
experiments, which are close to the outer surface of the vas
deferens, were either sensory or cholinergic.
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This work presents a first description of the pharmacology
of single varicosities when the agents to be examined might
have been expected to exert an eect on intra-varicosity
calcium. There are many questions that remain to be
addressed. These include whether the number of varicosities
examined in the present work are a sucient sample on which
to reach general conclusions, or whether there are pharmaco-
logical dierences between the subclasses of varicosities
defined on the basis of the D[Ca2+]v response to long trains
of stimuli. A valuable technical addition to the approach here
would be to combine confocal imaging of the immunohisto-
chemical localization of receptors on varicosities with the
D[Ca2+]v response to stimulation determined for the same
varicosities. The distribution of purinergic and adrenergic
receptors at single varicosities determined immunohistochemi-
cally is now under investigation (Hansen et al., 1998; Dutton et
al., 1999), so that this combined approach, which would couple
structure with function, will soon be possible.
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Appendix
Assume that the calcium concentration returns to its resting
level by a first order process, which has a time constant of t.
Hence, at a given time (t) the dierence in the calcium
concentration from its resting concentration (D[Ca2+]v), given
the perturbation above the resting concentration at time t=0
(D[Ca2+]v), is,
Ca2 Ca2oe
ÿ1

Suppose that calcium influx is triggered by a train of stimuli
at a frequency of n. Once dynamic equilibrium has been
established within the train, the calcium concentration decline
between each pulse must be equal to that added with the next
stimulus. If the peak elevation in calcium concentration is
D[Ca2+]v, then,
Ca2t ÿCa2te
ÿ1
  a
Hence,
Equation A1
Ca2t 
a
1ÿ eÿ1  A1
To find the average elevation in calcium concentration
during the plateau phase, when dynamic equilibrium has been
attained, we can average the calcium concentration over one
stimulus cycle, giving
Ca2 
R 1
v
0 Ca2t eÿ 1 dtR 1
v
o dt
and hence,
Ca2  Ca2t1ÿ e
ÿ1
 
Substituting D[Ca2+] from Equation A1 then gives,
Ca2  a
Hence, the plateau D[Ca2+] is proportional to change in
calcium concentration per impulse, the time constant of
calcium removal, and the frequency of stimulation. It can also
be noticed that the peak calcium concentration (from Equation
A1) is not proportional to the frequency of stimulation, except
in the limit as the frequency of stimulation becomes very large.
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